Literature DB >> 25182428

Exposure to perfluorinated compounds: in vitro study on thyroid cells.

Francesca Coperchini1, Patrizia Pignatti, Serena Lacerenza, Sara Negri, Riccardo Sideri, Claudia Testoni, Luca de Martinis, Danilo Cottica, Flavia Magri, Marcello Imbriani, Mario Rotondi, Luca Chiovato.   

Abstract

Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are widely used perfluorinated chemicals (PFCs). Previous studies detected PFOA and PFOS in human tissues including the thyroid gland. There are no studies on the in vitro effects of PFOA and PFOS on thyroid cells. Our study was aimed at evaluating the effect of the in vitro exposure to PFOA and PFOS on thyroid cell proliferation and viability. These objectives were investigated using Fisher rat thyroid line-5 (FRTL-5) cells. FRTL-5 cells cultured in the presence of PFOA and PFOS at concentrations up to 10(4) nM do not display changes in their viability and proliferation rate, while at a concentration of 10(5) nM of either PFCs, a significant inhibition of cell proliferation, mainly due to increased cell death, was found. PFOA and PFOS were detected in FRTL-5 cell pellets after 72 h of incubation with PFCs but not in control cultures. When FRTL-5 were incubated with PFCs then washed in PBS and re-cultured for 72 h without PFCs in the medium, no detectable concentrations of PFOA and PFOS were measured in the cell pellet. This indicates that PFOA and PFOS enter thyroid cells by a gradient-based passive diffusion mechanism. Future studies are required to evaluate the potential toxic effect resulting from prolonged in vivo exposure to even lower concentrations of PFCs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25182428     DOI: 10.1007/s11356-014-3480-9

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  36 in total

1.  Levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) in blood samples from different groups of adults living in Greece.

Authors:  Irene Vassiliadou; Danae Costopoulou; Angeliki Ferderigou; Leondios Leondiadis
Journal:  Chemosphere       Date:  2010-08       Impact factor: 7.086

2.  Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats.

Authors:  D M Gutshall; G D Pilcher; A E Langley
Journal:  J Toxicol Environ Health       Date:  1989

3.  Photodegradation of perfluorooctanoic acid by synthesized TiO2-MWCNT composites under 365nm UV irradiation.

Authors:  Chao Song; Peng Chen; Chunying Wang; Lingyan Zhu
Journal:  Chemosphere       Date:  2011-12-14       Impact factor: 7.086

4.  Fish consumption as a source of human exposure to perfluorinated alkyl substances in Sweden - analysis of edible fish from Lake Vättern and the Baltic Sea.

Authors:  Urs Berger; Anders Glynn; Katrin E Holmström; Marika Berglund; Emma Halldin Ankarberg; Anna Törnkvist
Journal:  Chemosphere       Date:  2009-05-19       Impact factor: 7.086

5.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.

Authors:  Kurunthachalam Kannan; Simonetta Corsolini; Jerzy Falandysz; Gilberto Fillmann; Kurunthachalam Senthil Kumar; Bommanna G Loganathan; Mustafa Ali Mohd; Jesus Olivero; Nathalie Van Wouwe; Jae Ho Yang; Kenneth M Aldoust
Journal:  Environ Sci Technol       Date:  2004-09-01       Impact factor: 9.028

6.  Thirty years of medical surveillance in perfluooctanoic acid production workers.

Authors:  Giovanni Costa; Samantha Sartori; Dario Consonni
Journal:  J Occup Environ Med       Date:  2009-03       Impact factor: 2.162

Review 7.  Perfluoroalkyl acids: a review of monitoring and toxicological findings.

Authors:  Christopher Lau; Katherine Anitole; Colette Hodes; David Lai; Andrea Pfahles-Hutchens; Jennifer Seed
Journal:  Toxicol Sci       Date:  2007-05-22       Impact factor: 4.849

8.  Mechanism of cytotoxic action of perfluorinated acids. I. alteration in plasma membrane potential and intracellular pH level.

Authors:  Konrad Kleszczyński; Andrzej C Składanowski
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-05       Impact factor: 4.219

9.  Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats.

Authors:  Andrew M Seacat; Peter J Thomford; Kris J Hansen; Lisa A Clemen; Sandra R Eldridge; Cliff R Elcombe; John L Butenhoff
Journal:  Toxicology       Date:  2003-02-01       Impact factor: 4.221

10.  Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells.

Authors:  Guoqiang Shan; Minqiang Ye; Benzhan Zhu; Lingyan Zhu
Journal:  Chemosphere       Date:  2013-08-22       Impact factor: 7.086

View more
  10 in total

Review 1.  Cosmetics as endocrine disruptors: are they a health risk?

Authors:  Polyxeni Nicolopoulou-Stamati; Luc Hens; Annie J Sasco
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

2.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

Review 3.  Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Authors:  F Coperchini; O Awwad; M Rotondi; F Santini; M Imbriani; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-11-11       Impact factor: 4.256

Review 4.  PFAS Molecules: A Major Concern for the Human Health and the Environment.

Authors:  Emiliano Panieri; Katarina Baralic; Danijela Djukic-Cosic; Aleksandra Buha Djordjevic; Luciano Saso
Journal:  Toxics       Date:  2022-01-18

Review 5.  Thyroid nodules and thyroid autoimmunity in the context of environmental pollution.

Authors:  Salvatore Benvenga; Alessandro Antonelli; Roberto Vita
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

Review 6.  Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.

Authors:  Ashlie Santaliz Casiano; Annah Lee; Dede Teteh; Zeynep Madak Erdogan; Lindsey Treviño
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

7.  Genetic background and window of exposure contribute to thyroid dysfunction promoted by low-dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice.

Authors:  Carla Reale; Immacolata Porreca; Filomena Russo; Maria Marotta; Luca Roberto; Nicola Antonino Russo; Emanuele Carchia; Massimo Mallardo; Mario De Felice; Concetta Ambrosino
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

Review 8.  Thyroid Disrupting Effects of Old and New Generation PFAS.

Authors:  Francesca Coperchini; Laura Croce; Gianluca Ricci; Flavia Magri; Mario Rotondi; Marcello Imbriani; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

9.  Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells In Vitro.

Authors:  Luca De Toni; Andrea Di Nisio; Maria Santa Rocca; Federica Pedrucci; Andrea Garolla; Stefano Dall'Acqua; Diego Guidolin; Alberto Ferlin; Carlo Foresta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

10.  The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.

Authors:  F Coperchini; L Croce; P Pignatti; G Ricci; D Gangemi; F Magri; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2020-12-14       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.